Physician profile
Brian Foster
NPI 1619133139
$1,722.26
in general payments reported to CMS, 2019-2025
14 companies · $563 in 2025
The $563 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $36.63 · 2021: $200 · 2023: $617 · 2024: $135 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,315.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $523.32 | 2024-2025 | Ofev |
| Amgen INC. | $245.32 | 2023 | Tezspire |
| Astrazeneca Pharmaceuticals Lp | $231.59 | 2023 | Tezspire, Fasenra |
| Zimmer Biomet Holdings, INC. | $223.44 | 2020-2021 | |
| Stryker Corporation | $119.53 | 2023-2025 | Mako, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Trice Medical, INC. | $97.52 | 2019 | |
| United Therapeutics Corporation | $85.97 | 2025 | Tyvaso |
| Djo, LLC | $72.11 | 2025 | Cmf |
| Lima USA, INC. | $31.65 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $26.06 | 2023 | Opsumit |
| Osteocentric Technologies, INC. | $22.90 | 2019 | |
| Skeletal Dynamics INC | $18.48 | 2019 | |
| Wright Medical Technology, INC. | $13.19 | 2020 | |
| Sonex Health, INC. | $11.18 | 2023 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.